MergerLinks Header Logo

Request Deal Involvement

Halozyme completed the acquisition of Antares Pharma for $960m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

FGS Global

pr advisors

FGS Global

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Jefferies & Company

financial advisors

Jefferies & Company

White & Case

legal advisors to financial advisors

White & Case

Fried Frank Harris Shriver & Jacobson

legal advisors to financial advisors

Fried Frank Harris Shriver & Jacobson

Weil Gotshal and Manges

legal advisors

Weil Gotshal and Manges

Joele Frank

pr advisors

Joele Frank

Argot Partners

pr advisors

Argot Partners

Wells Fargo Securities

financial advisors

Wells Fargo Securities

Bank of America

financial advisors

Bank of America

or

Principals

ANTARES PHARMA

target

ANTARES PHARMA

HALOZYME

bidder

HALOZYME

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Halozyme completed the acquisition of Antares Pharma for $960m.